Table Info

Table 2.

Patient clinical data

Variable	Value	Total	Percentage*
Longevity in clinic	≤ 6 months	19	6.2%
	7–12 months	29	9.5%
	13–18 months	14	4.6%
	19–24 months	13	4.3%
	> 24 months	228	74.8%
	No response	2	0.7%
Patient diagnoses	Rheumatoid arthritis	127	36.3%
	Systemic lupus erythematosus	76	21.7%
	Connective tissue disease	52	14.9%
	Undifferentiated inflammatory arthritis	16	4.6%
	Psoriatic arthritis	14	4.0%
	Gout	11	3.1%
	Vasculitis	12	3.4%
	Myositis	6	1.7%
	Polymyalgia rheumatica	2	0.6%
	Discoid lupus	1	0.3%
	Osteoporosis	1	0.3%
	Interstitial lung disease	1	0.3%
	Undiagnosed	27	7.7%
	No response	4	1.1%

* Percentages rounded off to 1 decimal place

Supplementary materials

The supplementary material for this article is available at: https://www.explorationpub.com/uploads/Article/file/101152_sup_1.pdf.

Declarations

Disclaimer

Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work.

Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work.

Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Acknowledgments

We would like to thank Mr. Daniel Cornwall for his assistance with data collection and data entry as a medical On-The-Job-Trainee.

Author contributions

ER: Conceptualization, Investigation, Methodology, Resources, Writing—original draft, Formal analysis, Project administration, Visualization, Writing—review & editing. HD: Conceptualization, Investigation, Methodology, Resources, Supervision. GR: Conceptualization, Methodology, Project administration, Validation, Supervision. All authors read and approved the submitted version.

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This study was approved by the Bioethics Committee of the South West Regional Health Authority with reference/approval number 2023-09-18-14-17.

Consent to participate

Informed consent to participate in the study was obtained from all participants.

Consent to publication

Not applicable.

Availability of data and materials

The dataset for this study will not be shared on an open access forum in compliance with ethical regulations associated with the South West Regional Health Authority. Data can be accessed via contacting the corresponding author.

Funding

Not applicable.

Copyright

Publisher’s note

Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.

References

Anawade PA, Sharma D, Gahane S. A Comprehensive Review on Exploring the Impact of Telemedicine on Healthcare Accessibility. Cureus. 2024;16:e55996. [DOI] [PubMed] [PMC]

WHO develops guidance to improve telemedicine services [Internet]. WHO; c2025. [cited 2025 Apr 13]. Available from: https://www.who.int/europe/news/item/15-07-2024-who-develops-guidance-to-improve-telemedicine-services

Tenforde AS, Hefner JE, Kodish-Wachs JE, Iaccarino MA, Paganoni S. Telehealth in Physical Medicine and Rehabilitation: A Narrative Review. PM&R. 2017;9:S51–8. [DOI] [PubMed]

COVID-19 has caused major disruptions and backlogs in health care, new WHO study finds [Internet]. WHO; 2025. [cited 2024 Oct 11]. Available from: https://www.who.int/europe/news/item/20-07-2022-covid-19-has-caused-major-disruptions-and-backlogs-in-health-care--new-who-study-finds

Defining Quality in Telehealth: An Urgent Pandemic Priority [Internet]. Cranbury: MJH Life Sciences; c2025. [cited 2024 Oct 11]. Available from: https://www.managedhealthcareexecutive.com/view/defining-quality-in-telehealth-an-urgent-pandemic-priority

COVID-19 and Telemedicine [Internet]. Pan American Health Organization; c2025. [cited 2024 Oct 11]. Available from: https://www.paho.org/en/documents/covid-19-and-telemedicine

Ferreira DC, Vieira I, Pedro MI, Caldas P, Varela M. Patient Satisfaction with Healthcare Services and the Techniques Used for its Assessment: A Systematic Literature Review and a Bibliometric Analysis. Healthcare (Basel). 2023;11:639. [DOI] [PubMed] [PMC]

Moulaei K, Sheikhtaheri A, Fatehi F, Shanbehzadeh M, Bahaadinbeigy K. Patients’ perspectives and preferences toward telemedicine versus in-person visits: a mixed-methods study on 1226 patients. BMC Med Inform Decis Mak. 2023;23:261. [DOI] [PubMed] [PMC]

Khan R, Gopaulsingh J, Gopee Z, Gould R, Gray A, Harripersad K, et al. The Effectiveness of Telemedicine in the Management of Chronic Diseases (Diabetes, Hypertension, and Coronary Heart Disease) at Primary Care Facilities in Eastern Trinidad During the COVID-19 Pandemic. Telemed J E Health. 2024;30:e2311–8. [DOI] [PubMed]

10.

Parmanto B, Lewis AN Jr, Graham KM, Bertolet MH. Development of the Telehealth Usability Questionnaire (TUQ). Int J Telerehabil. 2016;8:3–10. [DOI] [PubMed] [PMC]

11.

Telehealth [Internet]. Rockville: Agency for Healthcare Research and Quality. [cited 2024 Sep 26]. Available from: https://www.ahrq.gov/topics/telehealth.html

12.

Hajesmaeel-Gohari S, Bahaadinbeigy K. The most used questionnaires for evaluating telemedicine services. BMC Med Inform Decis Mak. 2021;21:36. [DOI] [PubMed] [PMC]

13.

Kong SS, Otalora Rojas LA, Ashour A, Robinson M, Hosterman T, Bhanusali N. Ability and willingness to utilize telemedicine among rheumatology patients-a cross-sectional survey. Clin Rheumatol. 2021;40:5087–93. [DOI] [PubMed] [PMC]

14.

George MD, Danila MI, Watrous D, Reddy S, Alper J, Xie F, et al. Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID‐19 Pandemic in a Community Practice-Based Network. Arthritis Care Res (Hoboken). 2021;73:1153–61. [DOI] [PubMed] [PMC]

15.

Pogorzelska K, Chlabicz S. Patient Satisfaction with Telemedicine during the COVID-19 Pandemic—A Systematic Review. Int J Environ Res Public Health. 2022;19:6113. [DOI] [PubMed] [PMC]

16.

Kruse CS, Krowski N, Rodriguez B, Tran L, Vela J, Brooks M. Telehealth and patient satisfaction: a systematic review and narrative analysis. BMJ Open. 2017;7:e016242. [DOI] [PubMed] [PMC]

17.

Dopelt K, Avni N, Haimov-Sadikov Y, Golan I, Davidovitch N. Telemedicine and eHealth Literacy in the Era of COVID-19: A Cross-Sectional Study in a Peripheral Clinic in Israel. Int J Environ Res Public Health. 2021;18:9556. [DOI] [PubMed] [PMC]

18.

Taylor-Gjevre R, Nair B, Bath B, Okpalauwaekwe U, Sharma M, Penz E, et al. Addressing rural and remote access disparities for patients with inflammatory arthritis through video-conferencing and innovative inter-professional care models. Musculoskeletal Care. 2018;16:90–5. [DOI] [PubMed]

19.

Ferucci ED, Day GM, Choromanski TL, Freeman SL. Outcomes and Quality of Care in Rheumatoid Arthritis With or Without Video Telemedicine Follow-Up Visits. Arthritis Care Res (Hoboken). 2022;74:484–92. [DOI] [PubMed] [PMC]

20.

Sloan M, Lever E, Harwood R, Gordon C, Wincup C, Blane M, et al. Telemedicine in rheumatology: a mixed methods study exploring acceptability, preferences and experiences among patients and clinicians. Rheumatology (Oxford). 2022;61:2262–74. [DOI] [PubMed] [PMC]

21.

So H, Chow E, Cheng IT, Lau SL, Li TK, Szeto CC, et al. Use of telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak: The 6-month results of a randomized controlled trial. Lupus. 2022;31:488–94. [DOI] [PubMed] [PMC]

22.

Conyette L, Haramnauth D, Beharry S. CS-17 Clinical and immunological profile of patients with systemic lupus erythematosus, attending the rheumatology clinics at the Southwest Regional Health Authority, Trinidad. Lupus Sci Med. 2018;5:A31–2. [DOI]

23.

Conyette L, Beharry S, Dyaanand H. CE-34 An analysis of the demographic data in patients with systemic lupus erythematosus in south and central Trinidad. Lupus Sci Med. 2016;3:A65–6. [DOI]

24.

Motilal S, Dawar A, Mankee A, Goberdhan N, Goberdhan V, Greene A, et al. Arthritis and Health-Related Quality of Life in Adult Outpatients in Trinidad: A Cross-Sectional Study. Caribb Med J. 2022. [DOI]

25.

Angum F, Khan T, Kaler J, Siddiqui L, Hussain A. The Prevalence of Autoimmune Disorders in Women: A Narrative Review. Cureus. 2020;12:e8094. [DOI] [PubMed] [PMC]

26.

Voskuhl R. Sex differences in autoimmune diseases. Biol Sex Differ. 2011;2:1. [DOI] [PubMed] [PMC]